CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-31 | Silva Francisco VP of Research and Development | Purchase | +747 | $3.56 | $3K | 159,690 |
| 2023-03-20 | Silva Francisco VP of Research and Development | Shares withheld for taxes | −6,729 | $2.92 | $20K | 158,943 |
| 2023-03-20 | ALSTODT LANCE President, CEO, COB | Shares withheld for taxes | −6,729 | $2.92 | $20K | 180,218 |
| 2023-02-22 | Broadrick Dale 10% owner | Purchase | +5,000 | $2.84 | $14K | 304,073 |
| 2023-02-22 | Broadrick Dale 10% owner | Purchase | +1,000 | $2.95 | $3K | 305,073 |
| 2023-02-18 | Silva Francisco VP of Research and Development | Shares withheld for taxes | −374 | $2.99 | $1K | 165,672 |
| 2023-02-18 | ALSTODT LANCE President, CEO, COB | Shares withheld for taxes | −374 | $2.99 | $1K | 186,947 |
| 2023-02-17 | Paccasassi Robert VP, QA and Reg Compliance | Grant or award · Stock Option | +88,968 | 88,968 | ||
| 2023-02-17 | Rosa David A Director | Grant or award · Stock Option | +32,028 | 32,028 | ||
| 2023-02-17 | Williams Patrick F. Director | Grant or award · Stock Option | +32,028 | 32,028 | ||
| 2023-02-17 | Kukekov Nickolay V. Director | Grant or award · Stock Option | +32,028 | 32,028 | ||
| 2023-02-17 | Kristal Robert Eugene Chief Financial Officer | Grant or award · Stock Option | +88,968 | 88,968 | ||
| 2023-02-17 | Silva Francisco VP of Research and Development | Grant or award · Stock Option | +106,762 | 106,762 | ||
| 2023-02-17 | ALSTODT LANCE President, CEO, COB | Grant or award · Stock Option | +106,762 | 106,762 | ||
| 2023-02-01 | ALSTODT LANCE President, CEO, COB | Purchase | +400 | $3.10 | $1K | 187,321 |
| 2023-01-27 | ALSTODT LANCE President, CEO, COB | Purchase | +200 | $3.01 | $602 | 186,921 |
| 2023-01-20 | ALSTODT LANCE President, CEO, COB | Purchase | +100 | $3.10 | $310 | 186,621 |
| 2023-01-20 | ALSTODT LANCE President, CEO, COB | Purchase | +100 | $3.17 | $317 | 186,721 |
| 2023-01-18 | ALSTODT LANCE President, CEO, COB | Purchase | +200 | $3.13 | $626 | 186,321 |
| 2023-01-18 | ALSTODT LANCE President, CEO, COB | Purchase | +100 | $3.10 | $310 | 186,421 |
Page 3 of 30 · 598 trades